SS
Satyapal Singh
About Satyapal Singh
Data last updated:
Satyapal Singh is a Director at Noverax Lifescience Private Limited (since 2025) and Director at Alderon Pharmaceutical Private Limited (since 2024). The companies operate in Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Noverax Lifescience Private Limited U46497MH2025PTC439653 | Director | 06 Feb 2025 | 2025 | Active | |
| Alderon Pharmaceutical Private Limited U33100DL2016PTC292926 | Director | 12 Dec 2024 | 2016 | Active |
Board colleagues of Satyapal Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sandeep Singh | 07460209 | Noverax Lifescience Private Limited , Alderon Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satyapal Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satyapal Singh
Satyapal Singh currently holds 2 directorships: Noverax Lifescience Private Limited (Director, since 06 Feb 2025); Alderon Pharmaceutical Private Limited (Director, since 12 Dec 2024).
Satyapal Singh was first appointed on 12 Dec 2024 as Director at Alderon Pharmaceutical Private Limited. The most recent appointment on record is 06 Feb 2025 at Noverax Lifescience Private Limited.
The current boards of Satyapal Singh's companies include Sandeep Singh (Noverax Lifescience Private Limited).